1.International Diabetes Federation (2017) IDF Diabetes Atlas, 8th edn. Brussels, Belgium: International Diabetes Federation. http://www.diabetesatlas.org.
2.Armstrong, DG, Boulton, AJM and Bus, SA (2017) Diabetic foot ulcers and their recurrence. New England Journal of Medicine 376, 2367–2375.
3.Roghmann, MC et al. (2001) MRSA colonization and the risk of MRSA bacteremia in hospitalized patients with chronic ulcers. Journal of Hospital Infection 47, 98–103.
4.Armstrong, DG, Liswood, PJ and Todd, WF (1995) 1995 prevalence of mixed infections in the diabetic pedal wound a retrospective review of 112 infections. Journal of the American Podiatric Medical Association 85, 533–537.
5.Tentolouris, N et al. (2006) Prevalence of methicillin-resistant Staphylococcus aureus in infected and uninfected diabetic foot ulcers. Clinical Microbiology and Infection 12, 186–189.
6.Lee, JS, Son, ST and Han, S (2017) Risk factors of methicillin-resistant Staphylococcus aureus and Pseudomonas infection in diabetic foot ulcers in Korea. Journal of Wound Management and Research 13, 29–34.
7.Trivedi, U et al. (2014) Prevalence of multiple antibiotic resistant infections in diabetic versus nondiabetic wounds. Journal of Pathogens 2014, 173053.
8.Ertugrul, BM et al. (2012) A prospective, multi-center study: factors related to the management of diabetic foot infections. European Journal of Clinical Microbiology and Infectious Diseases 31, 2345–2352.
9.Lipsky, BA et al. (2012) Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clinical Infectious Diseases 54, 1679–1684.
10.Young, H et al. (2015) Pseudomonas aeruginosa an uncommon cause of diabetic foot infection. Journal of the American Podiatric Medical Association 105, 125–129.
11.Powlson, AS and Coll, AP (2010) The treatment of diabetic foot infection. Journal of Antimicrobial Chemotherapy 65, 3–9.
12.Kandemir, O et al. (2007) Risk factors for infection of the diabetic foot with multi-antibiotic resistant microorganisms. Journal of Infection 54, 439–445.
13.Ji, X et al. (2014) Clinical characteristics and risk factors of diabetic foot ulcer with multidrug-resistant organism infection. International Journal of Low Extremity Wounds 13, 64–71.
14.Hartemann-Heurtier, A et al. (2004) Diabetic foot ulcer and multidrug-resistant organisms: risk factors and impact. Diabetic Medicine 21, 710–715.
15.Yates, C et al. (2009) Wound chronicity, inpatient care, and chronic kidney disease predispose to MRSA infection in diabetic foot ulcers. Diabetes Care 10, 1907–1909.
16.Lavery, LA et al. (2014) Risk factors for methicillin-resistant Staphylococcus aureus in diabetic foot infections. Diabetic Foot and Ankle 5, 23575.
17.Calcagno, V and Mazancourt, C (2010) Glmulti: an R package for easy automated model selection with (generalized) linear models. Journal of Statistical Software 34, 1–29.
18.Harrell, F (2001) Regression Modelling Strategies with Applications to Linear Models, Logistic Regression, and Survival Analysis. New York: Springer.
19.Hosmer, DW et al. (1997) A comparison of goodness-of-fit tests for the logistic regression model. Statistics in Medicine 16, 965–980.
20.Pepe, MS (2003) The Statistical Evaluation of Medical Tests for Classification and Prediction. New York: Oxford Statistical Science Series.
21.R: a language and environment for statistical computing. Available at http://www.r-project.org/ (Accessed 1 December 2017).
22.Harrell, FE (2018) Regression modeling strategies. R package version 5.1-1.
23.Chakraborti, C, Le, C and Yanofsky, A (2010) Sensitivity of superficial cultures in lower extremity wounds. Journal of Hospital Medicine 5, 415–420.
24.Eleftheriadou, I et al. (2010) Methicillin-resistant Staphylococcus aureus in diabetic foot infections. Drugs 70, 1785–1797.
25.Cadena, J et al. (2016) Risk factors for the development of active methicillin-resistant Staphylococcus aureus infection in patients colonized with MRSA at hospital admission. American Journal of Infection Control 44, 1617–1621.
26.Pickwell, K et al. (2015) Predictors of lower-extremity amputation in patients with an infected diabetic foot ulcer. Diabetes Care 38, 852–857.
27.Cohen, G, Haag-Weber, M and Horl, WH (1997) Immune dysfunction in uremia. Kidney International Supplement 62, 79–82.
28.Zavascki, AP, Cruz, RP and Goldani, LZ (2005) Risk factors for imipenem-resistant Pseudomonas aeruginosa: a comparative analysis of two case-control studies in hospitalized patients. Journal of Hospital Infection 59, 96–101.
29.Watters, C et al. (2013) Pseudomonas aeruginosa biofilms perturb wound resolution and antibiotic tolerance in diabetic mice. Medical Microbiology and Immunology 202, 131–141.
30.Apelqvist, J et al. (2008) Practical guidelines on the management and prevention of the diabetic foot. Diabetes/Metabolism Research and Reviews 24, 181–187.
31.Kono, Y and Muder, RR (2012) Identifying the incidence of and risk factors for reamputation among patients who underwent foot amputation. Annals of Vascular Surgery 26, 1120–1126.
32.Mandell, LA et al. (2007) Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clinical Infectious Diseases 44, 27–71.
33.Zhou, H et al. (2016) Utility of models to predict 28-day or 30-day unplanned hospital readmissions: an updated systematic review. British Medical Journal 6, 1–25.
34.Webb, B et al. (2016) The DRIP Score: derivation and prospective multi-center validation of a model to predict drug resistance in community-onset pneumonia. Antimicrobial Agents and Chemotherapy 60, 2652–2663.
35.Kim, CJ et al. (2015) Factors influencing culture positivity in pyogenic vertebral osteomyelitis patients with prior antibiotic exposure. Antimicrobial Agents and Chemotherapy 59, 2470–2473.